PCSK9 Inhibitors: The Need for a Patient-Centered Approach to Hyperlipidemia Management
Regeneron Pharmaceuticals, Inc.
Faculty Presenter
Ty J. Gluckman, MD
Medical Director, Center for Cardiovascular Analytics, Research and Data Science (CARDS)
Providence Heart Institute
Providence St. Joseph Health
Portland, Oregon
Medical Writer for Patient Counseling Script
Deep Patel, PharmD, MBA
Clinical Coordinator, Transitions of Care
Department of Pharmacy
Long Island Jewish Medical Center
New Hyde Park, New York
PCSK9 Inhibitors | Pharmacy Connect Podcast
Program Description
Hyperlipidemia is a chronic, progressive—but manageable—disease that contributes to atherosclerosis and cardiovascular disease. Statin therapy is the mainstay of treatment for hyperlipidemia and aims to lower LDL cholesterol to reduce risk of cardiovascular events, but some patients become nonadherent, intolerant, or resistant to therapy, which results in poorer clinical outcomes. Guidelines identify 4 main groups of patients for whom intensification of therapy with nonstatin medications, including PCSK9 inhibitors, may further reduce risk of ASCVD. This first webinar in a series of 3 highlights an overview of hyperlipidemia and updated guideline recommendations for healthcare professionals as they are intricately involved in identifying appropriate candidates for PCSK9 inhibitor therapy, educating patients, monitoring clinical responses, and working with clinicians to implement crucial interventions.
Target Audience: Managed care and retail pharmacists
Type of Activity: Application
Release date: January 7, 2021
Expiration date: July 7, 2022
Time to complete activity: 1.0 hour
Fee: Free
Educational Objectives
At the completion of this activity, participants will be able to:
- Explore the pathogenesis, epidemiology, burden, and risk factors of hyperlipidemia
- Analyze the current standard of care through hyperlipidemia treatment guidelines from the American Heart Association and the American College of Cardiology
- Illustrate the role of PCSK9 inhibitors in hyperlipidemia management and how to identify patients who may be appropriate candidates for these agents
Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 1.0 contact hour (0.10 CEU) under the ACPE universal activity number 0290-0000-21-004-H01-P. The activity is available for CE credit through July 7, 2022.
Instructions for Completing the Activity and Receiving CPE Credit
To receive CPE credit, participants must complete the pretest, view the webinar in its entirety, complete the posttest, and complete the online activity evaluation. After successful completion of the online activity evaluation, you can submit your credit to CPE Monitor. You may view your credit within 48 hours at www.mycpemonitor.net. All participants must request credit before the activity expiration date. CE credit will not be issued after this date.
Disclosures
Faculty
Ty J. Gluckman, MD, has no relevant financial relationships with commercial interests to disclose.
Pharmacy Times Continuing Education™ Planning Staff – Jim Palatine, RPh, MBA; Maryjo Dixon, RPh; Dipti Desai, PharmD, CHCP; Crissy Wilson; Susan Pordon; and Brianna Winters have no relevant financial relationships with commercial interests to disclose.
An anonymous peer reviewer is used as part of content validation and conflict resolution. The peer reviewer has no relevant financial relationships with commercial interests to disclose.
Educational Disclaimer
CPE activities are offered solely for educational purposes and do not constitute any form of professional advice or referral. Discussions concerning drugs, dosages, and procedures may reflect the clinical experience of the author(s) or they may be derived from the professional literature or other sources and may suggest uses that are investigational in nature and not approved labeling or indications. Participants are encouraged to refer to primary references or full prescribing information resources.
For questions about this internet CPE activity, please contact:
Privacy Policy and Terms of Use Information:
GET STARTED WITH THIS PROGRAM:
Register now to gain access to this program.
Create AccountAlready Registered? Login Here
